» Articles » PMID: 29133945

MicroRNA-7-5p Mediates the Signaling of Hepatocyte Growth Factor to Suppress Oncogenes in the MCF-10A Mammary Epithelial Cell

Overview
Journal Sci Rep
Specialty Science
Date 2017 Nov 15
PMID 29133945
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNA-7 (miR-7) is a non-coding RNA of 23-nucleotides that has been shown to act as a tumor suppressor in various cancers including breast cancer. Although there have been copious studies on the action mechanisms of miR-7, little is known about how the miR is controlled in the mammary cell. In this study, we performed a genome-wide expression analysis in miR-7-transfected MCF-10A breast cell line to explore the upstream regulators of miR-7. Analysis of the dysregulated target gene pool predicted hepatocyte growth factor (HGF) as the most plausible upstream regulator of miR-7. MiR-7 was upregulated in MCF-10A cells by HGF, and subsequently downregulated upon treatment with siRNA against HGF. However, the expression of HGF did not significantly change through either an upregulation or downregulation of miR-7 expression, suggesting that HGF acts upstream of miR-7. In addition, the target genes of miR-7, such as EGFR, KLF4, FAK, PAK1 and SET8, which are all known oncogenes, were downregulated in HGF-treated MCF-10A; in contrast, knocking down HGF recovered their expression. These results indicate that miR-7 mediates the activity of HGF to suppress oncogenic proteins, which inhibits the development of normal cells, at least MCF-10A, into cancerous cells.

Citing Articles

Molecular mechanism of the signaling axis regulating the progression of hepatocellular carcinoma.

Zhang N, Wang F, Zhu L, Chang R, Mok S, Peixoto R Ann Transl Med. 2023; 11(1):12.

PMID: 36760243 PMC: 9906214. DOI: 10.21037/atm-22-5929.


Aberrant expression of PI3K/AKT signaling is involved in apoptosis resistance of hepatocellular carcinoma.

Wang Z, Cui X, Hao G, He J Open Life Sci. 2021; 16(1):1037-1044.

PMID: 34632072 PMC: 8477673. DOI: 10.1515/biol-2021-0101.


Glucose Transporters as a Target for Anticancer Therapy.

Pliszka M, Szablewski L Cancers (Basel). 2021; 13(16).

PMID: 34439338 PMC: 8394807. DOI: 10.3390/cancers13164184.


MiR-7 in Cancer Development.

Korac P, Antica M, Matulic M Biomedicines. 2021; 9(3).

PMID: 33806891 PMC: 8004586. DOI: 10.3390/biomedicines9030325.


P21-Activated Kinase 1: Emerging biological functions and potential therapeutic targets in Cancer.

Yao D, Li C, Rajoka M, He Z, Huang J, Wang J Theranostics. 2020; 10(21):9741-9766.

PMID: 32863957 PMC: 7449905. DOI: 10.7150/thno.46913.


References
1.
Cochrane D, Cittelly D, Howe E, Spoelstra N, McKinsey E, LaPara K . MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer. Horm Cancer. 2011; 1(6):306-19. PMC: 4561556. DOI: 10.1007/s12672-010-0043-5. View

2.
Reddy S, Ohshiro K, Rayala S, Kumar R . MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions. Cancer Res. 2008; 68(20):8195-200. PMC: 3636563. DOI: 10.1158/0008-5472.CAN-08-2103. View

3.
Xie J, Chen M, Zhou J, Mo M, Zhu L, Liu Y . miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression. Oncol Rep. 2014; 31(4):1715-22. DOI: 10.3892/or.2014.3052. View

4.
Jeon H, Dracheva T, Yang S, Meerzaman D, Fukuoka J, Shakoori A . SMAD6 contributes to patient survival in non-small cell lung cancer and its knockdown reestablishes TGF-beta homeostasis in lung cancer cells. Cancer Res. 2008; 68(23):9686-92. PMC: 3617041. DOI: 10.1158/0008-5472.CAN-08-1083. View

5.
Houston S, McManus K, Adams M, Sims J, Carpenter P, Hendzel M . Catalytic function of the PR-Set7 histone H4 lysine 20 monomethyltransferase is essential for mitotic entry and genomic stability. J Biol Chem. 2008; 283(28):19478-88. PMC: 2443654. DOI: 10.1074/jbc.M710579200. View